GO:0035976 transcription factor AP-1 complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035976 describes the transcription factor AP-1 complex, a heterodimeric bZIP transcription factor composed of Fos, Jun, ATF, or JDP family proteins.
• AP-1 dimers bind TPA responsive elements (TRE) or cyclic AMP responsive elements (CRE) to regulate target gene transcription.
• AP-1 activity is rapidly induced by growth factors, cytokines, and stress signals, making it a central hub for signal transduction to gene expression.
• AP-1 is implicated in cancer, addiction, inflammation, and neuronal plasticity, with roles in both physiological and pathological contexts.
• AP-1 cooperates with chromatin remodeling complexes such as SWI/SNF to shape 3D enhancer landscapes and pioneer factor activity.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential to dissect AP-1 subunit-specific functions in disease and development.
Description
The transcription factor AP-1 complex (GO:0035976) is a dimeric transcription factor that integrates diverse extracellular signals into specific gene expression programs. It was originally identified as a protein complex that binds to the enhancer of the human metallothionein IIA gene and the TPA responsive element (TRE). AP-1 is composed of proteins from the Fos, Jun, ATF, and JDP families, which dimerize through a basic leucine zipper (bZIP) domain to form functional complexes. The combinatorial diversity of AP-1 subunits allows it to regulate a wide array of target genes in response to growth factors, cytokines, and stress stimuli. AP-1 is not a single protein but a collection of dimeric complexes with distinct DNA-binding preferences and transcriptional activities. Jun-Fos heterodimers preferentially bind TRE, while Jun-ATF dimers bind the cyclic AMP responsive element (CRE). This versatility enables AP-1 to participate in diverse biological processes, including cell proliferation, differentiation, apoptosis, and neuronal plasticity. Dysregulation of AP-1 is associated with cancer, addiction, and inflammatory diseases, making it a critical research focus. Understanding the composition, regulation, and function of the AP-1 complex is essential for deciphering how cells convert environmental cues into transcriptional outputs. Recent studies have revealed that AP-1 cooperates with chromatin remodeling complexes to shape enhancer landscapes, highlighting its role as a pioneer factor in establishing cell-type-specific gene expression. This article provides a comprehensive overview of GO:0035976, covering its structure, molecular mechanisms, key genes, disease relevance, and research methodologies, including CRISPR-based approaches.
transcription factor AP-1 complex At A Glance
| GO ID | GO:0035976 |
|---|---|
| GO term | transcription factor AP-1 complex |
| Ontology | cellular_component |
| Synonym | Activating protein 1 complex, AP-1 complex, AP1 complex, transcription factor AP1 complex |
| Major function | Sequence-specific DNA binding and transcriptional regulation of target genes in response to growth factors, cytokines, and stress |
| Subunit families | Fos (c-Fos, FosB, Fra-1, Fra-2), Jun (c-Jun, JunB, JunD), ATF (ATF2, ATF3, etc.), JDP (JDP1, JDP2) |
| DNA binding sites | TPA responsive element (TRE; 5'-TGAG/CTCA-3') and cyclic AMP responsive element (CRE; 5'-TGACGTCA-3') |
| Dimerization domain | Basic leucine zipper (bZIP) |
| Regulation | Induced by growth factors, cytokines, UV radiation, and stress; modulated by phosphorylation and interaction with cofactors |
What Is GO:0035976?
GO:0035976, the transcription factor AP-1 complex, is a heterodimeric transcription factor complex composed of proteins from the c-Fos, c-Jun, activating transcription factor (ATF), or JDP families. The subunits contain a basic leucine zipper (bZIP) domain that is essential for dimerization and DNA binding. Jun-Fos heterodimers bind preferentially to a heptamer consensus sequence known as the TPA responsive element (TRE), whereas Jun-ATF dimers bind the cyclic AMP responsive element (CRE) to regulate transcription of target genes. This complex acts as a signal-responsive transcription factor that converts extracellular stimuli into changes in gene expression.
Why Is transcription factor AP-1 complex Important in Cell Biology?
The AP-1 complex is a critical node in signal transduction, converting extracellular stimuli into specific transcriptional programs that control cell fate decisions. Its importance spans normal physiology, including development, immune responses, and neuronal plasticity, as well as pathology such as cancer, addiction, and inflammatory diseases. Because AP-1 subunits are encoded by immediate-early genes, their rapid induction allows cells to respond swiftly to environmental changes. Moreover, AP-1 serves as a paradigm for understanding combinatorial transcription factor function and signal integration. Research on AP-1 continues to reveal new roles in chromatin remodeling, enhancer selection, and 3D genome organization.
• AP-1 is a key mediator of immediate-early gene responses to growth factors, cytokines, and stress.
• It regulates cell proliferation, differentiation, apoptosis, and survival, influencing development and tissue homeostasis.
• AP-1 is implicated in cancer initiation and progression, with roles in tumor promotion, invasion, and metastasis.
• It contributes to drug addiction and neuronal plasticity, particularly in response to cocaine and other psychostimulants.
• AP-1 cooperates with chromatin remodeling complexes like SWI/SNF to establish enhancer landscapes and pioneer factor activity.
• It is a target for anti-inflammatory and anti-cancer therapies due to its role in cytokine production and inflammatory responses.
• AP-1 activation can be monitored using reporter systems, such as triple-parameter T cell reporter lines, for immunological studies.
• TRPV1 channel stimulation activates AP-1, linking sensory neuron activity to transcriptional changes.
• AP-1 subunits are frequently dysregulated in human tumors, making them potential biomarkers and therapeutic targets.
• Understanding AP-1 function requires precise genetic models, as subunit redundancy and compensation complicate interpretation.
Structure and Composition of transcription factor AP-1 complex
bZIP Domain and Dimerization
In simple terms: AP-1 proteins pair up using a zipper-like structure to form functional transcription factors.
The AP-1 complex is formed by dimerization of proteins from the Fos, Jun, ATF, and JDP families through their basic leucine zipper (bZIP) domains. The bZIP domain consists of a leucine zipper region that mediates dimerization and an adjacent basic region that contacts DNA. Dimerization is a prerequisite for DNA binding and transcriptional activity. Different dimer combinations confer distinct DNA-binding specificities and transcriptional outputs.
Fos and Jun Family Proteins
In simple terms: Fos and Jun proteins are the main building blocks of AP-1, and they combine in different pairs to control gene activity.
The Fos family includes c-Fos, FosB, Fra-1, and Fra-2, while the Jun family includes c-Jun, JunB, and JunD. Fos proteins cannot homodimerize but form heterodimers with Jun proteins, whereas Jun proteins can both homodimerize and heterodimerize with Fos or ATF proteins. The composition of AP-1 dimers determines their affinity for TRE versus CRE sites and their interactions with coactivators or corepressors. Fra-2, for example, has distinct roles in immune regulation and bone development.
ATF and JDP Family Proteins
In simple terms: ATF and JDP proteins are alternative partners that expand the range of AP-1 complexes and their target genes.
Activating transcription factor (ATF) family members, such as ATF2 and ATF3, can dimerize with Jun proteins to form AP-1 complexes that preferentially bind CRE sites. JDP proteins (JDP1 and JDP2) also contain bZIP domains and can dimerize with Jun or Fos proteins, often acting as repressors or modulators of AP-1 activity. The inclusion of ATF or JDP subunits alters the transcriptional outcome, allowing AP-1 to respond to diverse signaling pathways.
DNA Binding and Target Gene Recognition
In simple terms: AP-1 recognizes specific short DNA sequences in the genome to turn target genes on or off.
Jun-Fos heterodimers bind preferentially to the TPA responsive element (TRE; 5'-TGAG/CTCA-3'), a heptamer consensus sequence. Jun-ATF dimers bind the cyclic AMP responsive element (CRE; 5'-TGACGTCA-3'). The DNA-binding specificity is determined by the basic region of the bZIP domain and the dimer composition. Once bound, AP-1 recruits coactivators or corepressors to modulate transcription of target genes involved in proliferation, differentiation, and stress responses.
Interaction with Chromatin Remodeling Complexes
In simple terms: AP-1 works together with machines that open up DNA to help other factors access genes.
AP-1 can function as a pioneer factor that cooperates with the SWI/SNF chromatin remodeling complex to shape 3D enhancer landscapes. This cooperation facilitates nucleosome displacement and increases chromatin accessibility at enhancers, enabling the binding of additional transcription factors. Such interactions are critical for establishing cell-type-specific gene expression programs and for rapid responses to signaling cues.
Key Genes Involved in GO:0035976 transcription factor AP-1 complex
The following genes encode the major subunits and regulators of the transcription factor AP-1 complex, each with distinct roles in dimer composition, DNA binding, and transcriptional regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FOS | Encodes c-Fos, a subunit that heterodimerizes with Jun proteins to form AP-1 complexes binding TRE sites | Proto-oncogene; immediate-early response; widely used as a marker of neuronal activation |
| FOSB | Encodes FosB and its splice variant ΔFosB, which accumulate upon chronic stimulation | Key mediator of drug addiction and long-term neuronal plasticity |
| FOSL1 | Encodes Fra-1, a Fos family member that regulates proliferation and differentiation | Implicated in cancer progression and epithelial-mesenchymal transition |
| FOSL2 | Encodes Fra-2, which has roles in immune regulation and bone development | Associated with inflammatory diseases and osteosclerosis |
| JUN | Encodes c-Jun, the prototypical AP-1 subunit that can homodimerize or heterodimerize | Central to cell proliferation, apoptosis, and tumorigenesis |
| JUNB | Encodes JunB, a Jun family member with distinct target genes | Regulates hematopoiesis, inflammation, and bone metabolism |
| JUND | Encodes JunD, which often antagonizes c-Jun activity | Involved in aging, oxidative stress responses, and cancer |
| ATF2 | Encodes ATF2, which heterodimerizes with Jun to bind CRE sites | Plays roles in DNA damage response and stress signaling |
| ATF3 | Encodes ATF3, a stress-inducible ATF family member | Modulates inflammation and cancer cell survival |
| JDP2 | Encodes JDP2, a bZIP protein that can repress AP-1 activity | Involved in differentiation and tumor suppression |
| MAPK8 | Encodes JNK1, a kinase that phosphorylates c-Jun and enhances AP-1 activity | Critical for stress-induced AP-1 activation |
| MAPK9 | Encodes JNK2, another kinase activating c-Jun | Modulates AP-1-dependent apoptosis and proliferation |
| MAPK14 | Encodes p38α, which phosphorylates ATF2 and other AP-1 subunits | Links stress and inflammatory signals to AP-1 |
| TRPV1 | Encodes the capsaicin receptor; its stimulation activates AP-1 | Links sensory neuron activity to transcriptional responses |
| SMARCA4 | Encodes BRG1, a subunit of SWI/SNF that cooperates with AP-1 | Chromatin remodeling and enhancer regulation |
| SMARCB1 | Encodes SNF5/INI1, a core SWI/SNF subunit interacting with AP-1 | Tumor suppressor involved in enhancer maintenance |
| NFATC1 | Encodes NFATc1, a transcription factor that cooperates with AP-1 in immune cells | Costimulation and T cell activation reporter systems |
| RELA | Encodes NF-κB p65, which often co-occupies promoters with AP-1 | Inflammatory gene regulation and reporter assays |
How Is transcription factor AP-1 complex Regulated?
AP-1 activity is regulated at multiple levels, including transcription of its subunit genes, dimerization partner availability, post-translational modifications, and interactions with cofactors. Growth factors, cytokines, UV radiation, and stress activate signaling cascades such as the MAP kinase pathways, leading to phosphorylation of Jun and Fos proteins and enhanced AP-1 transcriptional activity. For example, JNK phosphorylates c-Jun at serine residues, increasing its transactivation potential. The composition of AP-1 dimers is also regulated by the relative abundance of each subunit, which can change in response to extracellular cues. Additionally, AP-1 activity can be modulated by interaction with chromatin remodeling complexes, such as SWI/SNF, which facilitate access to enhancer regions. Negative regulation occurs through the induction of inhibitory proteins like JDP2 or through feedback mechanisms that attenuate signaling.
transcription factor AP-1 complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FOS | Cancer, neuronal activation, addiction | Knockout mice, conditional overexpression, reporter lines |
| JUN | Cancer, proliferation, apoptosis | Point mutation (phosphorylation-deficient), knockout, overexpression |
| FOSB | Drug addiction, neuronal plasticity | Inducible transgenic overexpression of ΔFosB, knockout |
| ATF2 | Stress response, DNA damage, cancer | Knockout, point mutation (phospho-mutant), knock-in |
| TRPV1 | Pain, neurogenic inflammation | Knockout, knock-in (tagged), overexpression |
AP-1 in Cancer
AP-1 is frequently dysregulated in human cancers, where it contributes to tumor initiation, promotion, and progression. c-Jun and c-Fos are proto-oncogenes, and their overexpression or constitutive activation can drive uncontrolled proliferation and survival. AP-1 also promotes invasion and metastasis by inducing matrix metalloproteinases and other genes that remodel the extracellular matrix. In some contexts, AP-1 can exert tumor-suppressive functions, highlighting the context-dependent nature of its activity. Targeting AP-1 subunits or their upstream kinases is an active area of cancer therapeutic research.
AP-1 in Drug Addiction and Neuronal Plasticity
Chronic exposure to drugs of abuse, such as cocaine, induces stable changes in gene expression in the brain that underlie addiction. The AP-1 transcription factor complex, particularly ΔFosB, accumulates in the nucleus accumbens and other reward-related regions upon repeated drug administration. This accumulation mediates lasting transcriptional adaptations that contribute to drug-seeking behavior and relapse. AP-1 is therefore a key molecular switch in neuronal plasticity and addiction.
AP-1 in Inflammation and Immune Responses
AP-1 cooperates with other transcription factors, such as NF-κB and NFAT, to regulate genes involved in inflammation and immune responses. In T cells, AP-1 is required for the expression of cytokines like IL-2 and for productive T cell activation. AP-1 activation can be measured using triple-parameter reporter lines that simultaneously assess NF-κB, NFAT, and AP-1 activities. Dysregulated AP-1 activity contributes to chronic inflammatory diseases and autoimmune conditions.
AP-1 in Sensory Neurons and Pain
Stimulation of TRPV1 channels, which are expressed in sensory neurons, activates the AP-1 transcription factor. This activation links noxious stimuli and capsaicin exposure to changes in gene expression that may contribute to pain sensitization and neurogenic inflammation. AP-1 therefore serves as a downstream effector of TRPV1 signaling in nociceptive pathways.
From transcription factor AP-1 complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of c-Jun affect cell proliferation? | JUN knockout cell lines or conditional knockout mice |
| How does phosphorylation of c-Jun at Ser73 regulate AP-1 activity? | Point mutation (S73A) knock-in via CRISPR |
| What is the role of ΔFosB in addiction? | Inducible overexpression of FosB in mouse brain |
| How does AP-1 cooperate with SWI/SNF at enhancers? | Tagged knock-in of AP-1 subunits and SMARCA4 for ChIP-seq |
| Can AP-1 activity be monitored in live cells? | Reporter cell lines with AP-1-driven luciferase or fluorescent proteins |
| What are the target genes of Fra-2 in immune cells? | FOSL2 knockout and RNA-seq |
How to Study the transcription factor AP-1 complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identifying AP-1 target genes and transcriptional programs |
| ChIP-seq | Genome-wide DNA binding sites | Mapping AP-1 occupancy at TRE/CRE and enhancers |
| ATAC-seq | Chromatin accessibility | Assessing AP-1 pioneer activity and enhancer remodeling |
| Luciferase reporter assay | AP-1 transcriptional activity | Screening for activators or inhibitors of AP-1 |
| Western blot | Protein expression and phosphorylation | Detecting c-Fos, c-Jun, and phospho-c-Jun levels |
| Immunofluorescence | Subcellular localization | Visualizing AP-1 nuclear translocation |
| Co-immunoprecipitation | Protein-protein interactions | Identifying AP-1 dimer partners and cofactors |
| CRISPR screening | Gene essentiality and modifiers | Discovering regulators of AP-1 activity |
Transcriptomic Profiling (RNA-seq)
RNA sequencing is widely used to identify AP-1 target genes and to assess transcriptional changes upon AP-1 perturbation. By comparing wild-type and AP-1 subunit knockout cells, researchers can define the AP-1-dependent transcriptome. RNA-seq also reveals context-specific gene expression programs and can be combined with chromatin accessibility assays to link AP-1 binding to gene regulation.
Chromatin Immunoprecipitation (ChIP-seq)
ChIP-seq using antibodies against AP-1 subunits or tagged knock-in proteins allows genome-wide mapping of AP-1 binding sites. This method identifies TRE and CRE elements occupied by AP-1 and reveals cooperative interactions with other transcription factors and chromatin remodelers. ChIP-seq is essential for understanding how AP-1 shapes enhancer landscapes and 3D genome organization.
Reporter Assays for AP-1 Activity
Luciferase or fluorescent reporter constructs driven by AP-1 response elements are used to measure AP-1 transcriptional activity in live cells. Triple-parameter reporter lines enable simultaneous measurement of NF-κB, NFAT, and AP-1 activities, which is useful for studying T cell activation and costimulation. These assays are high-throughput and suitable for screening modulators of AP-1 signaling.
Proteomics and Phosphoproteomics
Mass spectrometry-based proteomics can identify AP-1 interaction partners and post-translational modifications that regulate its activity. Phosphoproteomics reveals signaling events, such as JNK-mediated phosphorylation of c-Jun, that control AP-1 function. These approaches provide a systems-level view of AP-1 regulation and crosstalk with other pathways.
How CRISPR Can Be Used to Study GO:0035976 transcription factor AP-1 complex
Knockout
CRISPR knockout of AP-1 subunit genes (e.g., JUN, FOS, FOSB) in cell lines or primary cells enables loss-of-function studies to determine their roles in proliferation, differentiation, and stress responses. Knockout models are particularly useful for dissecting subunit-specific functions and for identifying compensatory mechanisms. However, redundancy among family members may require combinatorial knockouts.
Point Mutation
CRISPR-mediated point mutations can introduce phospho-deficient or phospho-mimetic residues in AP-1 subunits, such as c-Jun S73A, to study the impact of post-translational modifications on AP-1 activity. These models provide precise mechanistic insights without altering protein expression levels. Point mutations can also disrupt DNA-binding residues to separate DNA binding from protein-protein interactions.
Knock-in
Knock-in of epitope tags (e.g., HA, FLAG) or fluorescent proteins into endogenous AP-1 subunit loci allows for ChIP-seq, imaging, and proteomic studies under physiological expression conditions. Tagged knock-in models are valuable for mapping AP-1 binding sites and studying dimer composition in vivo. Knock-in of reporter cassettes can also enable real-time monitoring of AP-1 activity.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can drive constitutive AP-1 subunit expression to study gain-of-function effects, such as oncogenic transformation or drug resistance. Overexpression models are useful for identifying downstream target genes and for testing therapeutic interventions. Inducible overexpression systems allow temporal control of AP-1 activity.
How EDITGENE Supports transcription factor AP-1 complex Research
Researchers studying transcription factor AP-1 complex-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. Precise genetic models are essential to move from correlation to causation, and CRISPR-based approaches provide the necessary tools to manipulate AP-1 subunits and their regulators with high specificity.
Contact EDITGENE today to design your custom CRISPR model for transcription factor AP-1 complex research.
Frequently Asked Questions About transcription factor AP-1 complex
What is the transcription factor AP-1 complex?
The transcription factor AP-1 complex (GO:0035976) is a heterodimeric transcription factor composed of Fos, Jun, ATF, or JDP family proteins that binds TRE or CRE DNA elements to regulate gene expression.
What genes are involved in the transcription factor AP-1 complex?
Key genes include FOS, FOSB, FOSL1, FOSL2, JUN, JUNB, JUND, ATF2, ATF3, and JDP2, which encode the subunits that dimerize to form AP-1 complexes.
What is the function of AP-1 in cells?
AP-1 regulates transcription of target genes in response to growth factors, cytokines, and stress, controlling processes such as proliferation, differentiation, apoptosis, and neuronal plasticity.
How is AP-1 activated?
AP-1 is activated by signaling pathways such as MAP kinases, which phosphorylate its subunits and enhance transcriptional activity. It is induced by growth factors, cytokines, UV radiation, and stress.
What diseases are associated with AP-1?
AP-1 is implicated in cancer, drug addiction, inflammatory diseases, and pain sensitization, among other conditions.
How can I study AP-1 using CRISPR?
CRISPR can be used to generate knockout, point mutation, knock-in, or overexpression models of AP-1 subunits to study their functions in vitro and in vivo.
What is the difference between TRE and CRE?
TRE (TPA responsive element) is bound preferentially by Jun-Fos heterodimers, while CRE (cyclic AMP responsive element) is bound by Jun-ATF dimers, leading to distinct transcriptional outcomes.
What is the role of AP-1 in cancer?
AP-1 contributes to cancer by promoting proliferation, survival, invasion, and metastasis, and its subunits are often dysregulated in human tumors.
How is AP-1 activity measured in the lab?
AP-1 activity can be measured using luciferase or fluorescent reporter assays, ChIP-seq for DNA binding, and RNA-seq for target gene expression.
What is the role of AP-1 in drug addiction?
Chronic drug exposure induces stable AP-1 complexes, particularly ΔFosB, in reward-related brain regions, mediating long-term transcriptional changes that underlie addiction.
Conclusion
The transcription factor AP-1 complex (GO:0035976) is a versatile and dynamic regulator of gene expression that integrates diverse signaling inputs to control fundamental cellular processes. Its combinatorial subunit composition, DNA-binding specificity, and cooperation with chromatin remodelers make it a paradigm for understanding signal-dependent transcription. Dysregulation of AP-1 is linked to cancer, addiction, inflammation, and pain, underscoring its clinical relevance. Advances in CRISPR-based models and high-throughput methods continue to illuminate the complex biology of AP-1, offering new opportunities for therapeutic intervention.
References
- 1. Karin M et al.. 1997. AP-1 function and regulation.. Curr Opin Cell Biol 9(2):240-6 PMID: 9069263
- 2. Hope BT. 1998. Cocaine and the AP-1 transcription factor complex.. Ann N Y Acad Sci 844:1-6 PMID: 9668659
- 4. Foletta VC. 1996. Transcription factor AP-1, and the role of Fra-2.. Immunol Cell Biol 74(2):121-33 PMID: 8723999
- 5. Wolf BK et al.. 2023. Cooperation of chromatin remodeling SWI/SNF complex and pioneer factor AP-1 shapes 3D enhancer landscapes.. Nat Struct Mol Biol 30(1):10-21 PMID: 36522426
- 6. Bejjani F et al.. 2019. The AP-1 transcriptional complex: Local switch or remote command?. Biochim Biophys Acta Rev Cancer 1872(1):11-23 PMID: 31034924
- 7. Backes TM et al.. 2018. Stimulation of TRPV1 channels activates the AP-1 transcription factor.. Biochem Pharmacol 150:160-169 PMID: 29452097
- 8. Jutz S et al.. 2016. Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: Simultaneous measurement of NF-κB, NFAT and AP-1.. J Immunol Methods 430:10-20 PMID: 26780292
